Whether youre considering AOD-9604 for fat loss support, metabolic optimization, or body recomposition, this guide provides the scientific foundation you need to make an informed decision
Survodutide: The GLP-1/Glucagon Dual Agonist Redefining Metabolic Research Survodutide (BI 456906) pairs GLP-1 and glucagon receptor activation without GIP a distinct dual-agonist profile that has drawn significant research interest for NASH, visceral fat reduction, and hepatic metabolic disease endpoints
Disclaimer below: This content is provided for educational purposes only, is not intended as medical advice, has not been evaluated by the FDA, and is not intended to diagnose, treat, cure, or prevent any disease
Thus, scientists must note that unanticipated reactions may emerge as research progresses